Loading organizations...
Loading organizations...
Inhalation therapies for chronic respiratory and CNS diseases.
Chance Pharmaceuticals has raised $30.0M across 1 funding round.
Chance Pharmaceuticals has raised $30.0M in total across 1 funding round.
Chance Pharmaceuticals has raised $30.0M in total across 1 funding round.
Chance Pharmaceuticals's investors include Zhihua Yu, Guozhong Capital, HEDA BioVenture.
Chance Pharmaceuticals has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series C in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 12, 2021 | $30.0M Series C | Zhihua Yu | Guozhong Capital, HEDA BioVenture |